Select Page

Neuland Laboratories (Large Cap - Next Multibagger) Share Target 2024, 2025 To 2039

Neuland Laboratories Limited

Company Logo Price: ₹13,891.15
52 Week Low: ₹4,926.05
52 Week High: ₹18,100.00
Market Capital: 20,002.13 Crore (Largecap)
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

To predict the Neuland Laboratories's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Neuland Laboratories Share Price Target For 2024

The line chart displays the monthly closing prices of Neuland Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Neuland Laboratories shares in 2024, see the table below.

Neuland Laboratories Share Price Target Table For 2024

Level Value Analysis
2024 Target 3 14854.45 (+6.93%) Price Action: 19 Dec 2024 High
2024 Target 2 14700.0 (+5.82%) Price Action: 25 Nov 2024 Low
2024 Target 1 14544.29 (+4.70%) Price Action: 13 Nov 2024 Low
Current Price 13891.15 Neuland Laboratories's share price as of 20 Dec 2024
Stop Loss 1 13558.59 (-2.40%) Price Action: 28 Oct 2024 Low
Stop Loss 2 13423.0 (-3.38%) Price Action: Chart
Stop Loss 3 13181.39 (-5.11%) Price Action: Chart

Short-Term Technical Outlook

Current Technical Position: Neuland Laboratories is displaying bearish momentum trading below key moving averages.

Key Technical Level: The 50-day moving average at ₹15077.33 serves as the nearest technical reference point.

Historical Returns: 3-month: +12.15% | 6-month: +85.91% | 1-year: +162.98%

Neuland Laboratories Share Price Target For 2025

The line chart displays the monthly closing prices of Neuland Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Neuland Laboratories shares in 2025, see the table below.

Neuland Laboratories Share Price Target Table For 2025

Level Value Analysis
2025 Target 3 23101.79 (+66.30%) Price Action: Chart
2025 Target 2 22671.04 (+63.20%) Price Action: Chart
2025 Target 1 22446.57 (+61.58%) Fibonacci Extension Level 64.90%
Current Price 13891.15 Neuland Laboratories's share price as of 20 Dec 2024
Stop Loss 1 11508.76 (-17.16%) Fibonacci Retracement Level 50.00%
Stop Loss 2 11384.67 (-18.05%) Technical Indicator: MA150
Stop Loss 3 11179.75 (-19.52%) Price Action: Chart

Long-Term Technical Outlook

52-Week Range Analysis: Neuland Laboratories is currently trading at 68.1% of its 52-week range (₹4926.05 - ₹18100).

Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.

Long-Term Performance: 1-year: +162.98% | 3-year: +807.56% | 5-year: +3,278.77%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Neuland Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039

Year Target 1 Target 1 YoY Chg % Target 2
Current Price ₹13,891.15
2024 ₹16,846.62 +21.28% ₹17,099.32
2025 ₹29,056.61 +72.48% ₹29,492.46
2026 ₹36,714.70 +26.36% ₹37,265.42
2027 ₹47,517.25 +29.42% ₹48,230.01
2028 ₹60,882.12 +28.13% ₹61,795.35
2029 ₹75,529.32 +24.06% ₹76,662.26
2030 ₹88,711.32 +17.45% ₹90,041.99
2031 ₹90,150.56 +1.62% ₹91,502.82
2032 ₹101,083.17 +12.13% ₹102,599.42
2033 ₹116,887.32 +15.63% ₹118,640.63
2034 ₹134,212.02 +14.82% ₹136,225.20
2035 ₹148,366.03 +10.55% ₹150,591.52
2036 ₹143,586.41 -3.22% ₹148,882.70
2037 ₹154,649.09 +7.70% ₹163,553.37
2038 ₹172,892.52 +11.80% ₹178,224.05
2039 ₹190,273.07 +10.05% ₹193,127.17

Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.

Neuland Laboratories Brief Company Overview

Neuland Laboratories Limited: A Global Leader in API Manufacturing Overview: Neuland Laboratories Limited, established in 1984, is a renowned manufacturer of active pharmaceutical ingredients (APIs) Key Products and Services: APIs for diverse therapeutic areas including... antiasthmatics, cardiovasculars, antifungal, anticonvulsants, CNS, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson Custom manufacturing solutions Peptide synthesis services Global Presence: Neuland Laboratories has a strong global footprint, operating in India, Europe, the United States, and internationally. Commitment: The company is committed to providing high-quality APIs and custom manufacturing solutions to its customers worldwide. Reputation: Neuland Laboratories Limited has established a strong reputation in the industry for its reliable manufacturing capabilities and diverse product range.

Neuland Laboratories Financial Performance

Metric Value Description
Market Capital 20,002.13 Crore Market valuation of Neuland Laboratories's shares.
Revenue (TTM) 1,528.28 Crore Total revenue generated by Neuland Laboratories over the past twelve months.
Net Income (TTM) +2,796,675,072.00 Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin +14.84% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin +18.29% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
-25.60% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
-63.20% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
7.84 Company's total debt divided by total shareholder equity.
Total Debt 109.48 Crore Sum of Neuland Laboratories's current & long-term financial obligations.
Total Cash 190.36 Crore Total amount of liquid funds available to Neuland Laboratories.
Beta 0.98 Beta is less than 1 indicating that the Neuland Laboratories's price is less volatile than the market.

Is Neuland Laboratories A Good Buy For Long Term?

No valid response content found

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.